Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 30, 1994
Integrated control of cell proliferation and cell death by the c-myc oncogeneG Evan, E Harrington, A Fanidi, et al.Nature|October 8, 1992
Cooperative interaction between c-myc and bcl-2 proto-oncogenesA Fanidi, E A Harrington, G I EvanCurrent Opinion in Genetics & Development|February 1, 1994
Oncogenes and cell deathE A Harrington, A Fanidi, G I EvanJournal of Virology|September 12, 1998
Suppression of c-Myc-induced apoptosis by the Epstein-Barr virus gene product BHRF1A Fanidi, D C Hancock, T D LittlewoodJournal of Steroid Biochemistry|March 1, 1990
Modulation of quail oviduct adenylate cyclase activity by estradiol and progesteroneC Courion-Guichardaz, A Fanidi, J F Pageaux, et al.Biochemical and Biophysical Research Communications|May 31, 1991
Differential regulation of calmodulin-dependent and -independent cyclic AMP phosphodiesterases from oviduct by fatty acidsC Laugier, N Zebda, A Fanidi, et al.The EMBO Journal|July 15, 1994
c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokinesE A Harrington, M R Bennett, A Fanidi, et al.Endocrinology|September 1, 1989
Effects of tamoxifen, tamoxifen metabolites, and nafoxidine on adenosine 3',5'-monophosphate phosphodiesterase: correlations with growth inhibitory activities but not estrogen receptor affinitiesA Fanidi, C Courion-Guichardaz, J M Fayard, et al.The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1992
Opposite regulation of cAMP concentration in the quail oviduct and the mouse uterus by tamoxifen. Correlation with estrogen-antagonist and estrogen-agonist activityA Fanidi, C Ahnadi, J M Fayard, et al.Biology of the Cell|January 1, 1991
Growth inhibition and the regulation of cyclic AMP by the triphenylethylene anti-estrogen tamoxifen in the quail oviductA Fanidi, J F Pageaux, C Courion, et al.Pageof 7